138 results on '"Torikai, Hiroki"'
Search Results
2. NKT cells have prolonged persistence and antitumor activity in vivo
3. A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR
4. CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo
5. HapMap scanning of novel human minor histocompatibility antigens
6. Engineering T Cells to Target Tumor Cells
7. Identification of human minor histocompatibility antigens based on genetic association with highly parallel genotyping of pooled DNA
8. A high throughput microelectroporation device to introduce a chimeric antigen receptor to redirect the specificity of human T cells
9. Aberrant expression of BCL2A1-restricted minor histocompatibility antigens in melanoma cells: application for allogeneic transplantation
10. Histiocytic sarcoma of the spleen: case report of asymptomatic onset of thrombocytopenia and complex imaging features
11. Alternative splicing due to an intronic SNP in HMSD generates a novel minor histocompatibility antigen
12. Mismatched human leukocyte antigen class II-restricted CD8+ cytotoxic T cells may mediate selective graft-versus-leukemia effects following allogeneic hematopoietic cell transplantation
13. Very rapid cloning, expression and identifying specificity of T-cell receptors for T-cell engineering
14. Bone marrow may be a reservoir of long-lived memory T cells specific for minor histocompatibility antigen
15. Adoptive T-Cell Therapy with TCL1-Specific TCR for B-Cell Lymphomas
16. Abstract 2566: A TCL1-specific T-cell receptor redirects T cells against B-cell lymphomas and non-hematological tumors
17. Non-viral gene transfer with Sleeping Beauty system to engineer T cells for hematologic malignancies and solid tumors
18. Personalization of T-Cell Therapy Using a High-Throughput Platform to Identify Tumor-Specific T-Cell Receptors
19. Targeting B-cell malignancies through human B-cell receptor specific CD4+T cells
20. Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of VL and VH Domains Targeting CD123+ Tumors
21. Translational Implications for Off-the-shelf Immune Cells Expressing Chimeric Antigen Receptors
22. Redirecting T-Cell Specificity to EGFR Using mRNA to Self-limit Expression of Chimeric Antigen Receptor
23. Genetic editing of HLA expression in hematopoietic stem cells to broaden their human application
24. Targeting B cell malignancies through human B cell receptor specific CD4 T cells
25. 410. The Development of HLAnull K562 Cells Expressing CD1d and Co-Stimulatory Molecules as Artificial Antigen-Presenting Cells for Clinical Scale Expansion of NKT Cells With Superior In Vivo Persistence and Anti-Tumor Potential
26. ZFN-Driven Gene Editing Prevents HLA-A Expression On Hematopoietic Stem Cells -Improving The Chance Of Finding An HLA-Matched Donor
27. Toward eliminating HLA class I expression to generate universal cells from allogeneic donors
28. The development of genetically modified K562 cells as artificial antigen presenting cells for NKT cells (P4310)
29. Abstract 3961: IL-15 improves the effect of adoptive T cell therapy through cellular senescence delay.
30. Sleeping Beauty System to Redirect T-cell Specificity for Human Applications
31. Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of VL and VH Domains Targeting CD123+ Tumors.
32. Autophagy Creates a CTL Epitope That Mimics Tumor-Associated Antigens
33. HLA and TCR Knockout by Zinc Finger Nucleases: Toward “off-the-Shelf” Allogeneic T-Cell Therapy for CD19+ Malignancies.
34. HapMap Scanning of Novel Human Minor Histocompatibility Antigens
35. Transformation of myelodysplastic syndrome into myeloid/natural killer cell precursor acute leukemia involving mainly lymph nodes
36. Histiocytic sarcoma of the spleen: case report of asymptomatic onset of thrombocytopenia and complex imaging features
37. Impacts of ABO-Blood Type Incompatibility on Outcome of Unrelated Bone Marrow Transplantation through the Japan Marrow Donor Program.
38. Alternative Splicing Due to an Intronic SNP Defines a Novel HLA-B44-Restricted-Hematopoiesis-Restricted Minor Histocompatibility Antigen.
39. BCR/ABL Promotes Neutrophil Differentiation through Downregulation of c-jun Expression.
40. Myeloid/NK cell precursor acute leukemia lost both CD13 and CD33 at first diagnosis
41. Identification of an HLA-A24-restricted cytotoxic T lymphocyte epitope from human papillomavirus type-16 E6: The combined effects of bortezomib and interferon-γ on the presentation of a cryptic epitope
42. Elevated Expression of C/EBPα/ε and c-myb Is Required for Myeloid Differentiation in CML.
43. HHV-6 encephalitis after unrelated cord blood transplantation in a patient with acute lymphoblastic leukemia.
44. A Novel HLA-A*3303-Restricted Minor Histocompatibility Antigen Encoded by an Unconventional Open Reading Frame of Human TMSB4Y Gene
45. Identification of an HLA-A24-restricted cytotoxic T lymphocyte epitope from human papillomavirus type-16 E6: The combined effects of bortezomib and interferon-γ on the presentation of a cryptic epitope.
46. Alternative splicing due to an intronic SNP in HMSDgenerates a novel minor histocompatibility antigen
47. Targeting B-cell malignancies through human B-cell receptor specific CD4 T cells.
48. CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo.
49. [Methicillin-resistant Staphylococcus aureus-induced pyomyositis that emerged during recovery from drug-induced pancytopenia].
50. Identification of an HLA-A24-restricted cytotoxic T lymphocyte epitope from human papillomavirus type-16 E6: the combined effects of bortezomib and interferon-gamma on the presentation of a cryptic epitope.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.